Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Other Working Capital Changes of -$3000.0 for Q1 2026, up 25.0% sequentially from -$4000.0 in Q4 2025, and down 113.04% YoY from $23000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Other Working Capital Changes for 3 years, with the latest figure at -$3000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 113.04% year-over-year to -$3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$544000.0 (down 313.33% YoY) and the FY2025 annual result came in at -$518000.0, down 328.19% from the prior year.
- Other Working Capital Changes rose to -$3000.0 in Q1 2026 per CNTB's latest filing, from -$4000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.2 million in Q2 2025 and troughed at -$1.6 million in Q4 2024.
- A 3-year average of $229666.7 and a median of -$42000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 560.0% in 2025, down 8783.33% in 2025.
- Over 3 years, Other Working Capital Changes stood at -$9000.0 in 2024, then surged by 55.56% to -$4000.0 in 2025, then climbed by 25.0% to -$3000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$3000.0, -$4000.0, and -$4000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5,000.00 |
| Jun 30, 2026 | -5,000.00 |
| Jun 30, 2026 | -5,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -533,000.00 |
| Jun 30, 2025 | -533,000.00 |
| Jun 30, 2025 | -533,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |